Hot Lines - Congreso Europeo de Cardiología 2014
www.revespcardiol.org/es
www.revespcardiol.org/en
Estimados colegas:
En relación al Congreso Europeo de Cardiología 2014, te comunicamos que puedes encontrar en nuestro bloglos resultados y comentarios de las sesiones Hot Line:
Dear Colleagues,
In relation to the European Society of Cardiology Congress 2014, you will find in Rev Esp Cardiol blog the main results and comments to the studies presented in the Hot Line sessions:
Hot Line: Cardiovascular disease: novel therapies - 31/08/2014
Results of the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
Milton PACKER (Dallas, US).
A Randomized Controlled Trial of Vagal Stimulation for the Treatment of Systolic Heart Failure: Neural Cardiac Therapy for Heart Failure (NECTAR-HF).
Faiez ZANNAD (Vandoeuvre Les Nancy, FR).
Effect of Ferric Carboxymaltose on Functional Capacity in Patients With Heart Failure and Iron Deficiency
Piotr PONIKOWSKI (Wroclaw, PL).
Cardiac Resynchronization Therapy With a Novel Quadripolar Lead Decreases Complications at Six Months: Preliminary Results of the MORE-CRT Trial.
Giuseppe BORIANI (Bologna, IT).
Colchicine for Post- operative Pericardial Effusion: The Post-operative Pericardial Effusion (POPE-2) Study. A Multicenter, Double-blind, Randomized Trial.
Philippe MEURIN (Villeneuve-St.-Denis, FR).
Colchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial).
Massimo IMAZIO (Torino, IT).
Hot Line: Coronary artery disease and lipids - 31/08/2014
The Stabilization of Plaques Using Darapladib -Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial: Primary Results.
Michelle O'DONOGHUE (Boston, US).
Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure: The Results of SIGNIFY.
Kim FOX (London, GB).
Efficacy and Safety of Alirocumab in High Cardiovascular Risk Patients With Inadequately Controlled Hypercholesterolaemia on Maximally Tolerated Daily Statin: Results From The ODYSSEY COMBO II Study.
Christopher Paul CANNON (Boston, US).
Efficacy and Safety of Alirocumab in Patients With Heterozygous Familial Hypercholesterolaemia not Adequately Controlled With Current Lipid-lowering Therapy: Results of ODYSSEY FH I and FH II Studies.
Michel FARNIER (Dijon, FR).
Long-term Safety, Tolerability and Efficacy of Alirocumab Versus Placebo in High Cardiovascular Risk Patients: First Results From the ODYSSEY LONG TERM Study in 2341 Patients. Jennifer Robinson (Iowa City, US).
The Differences of the Effects on Lipid-lowering Actions and Glucose Metabolisms Between Rosuvastatin and Atorvastatin in Japanese Diabetic Patients With Hyperlipidemia.
Hisao OGAWA (Kumamoto, JP).
Hot Line: Heart failure: devices and interventions - 01/09/2014
Randomized Comparison of a Novel, Ultrathin Strut Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent for Percutaneous Coronary Revascularization.
Thomas PILGRIM (Bern, CH).
Autonomic Regulation Therapy for the Improvement of Left Ventricular Function and Heart Failure Symptoms: The ANTHEM-HF Study.
Inder ANAND (Minneapolis, US).
Biventricular Pacing for Atrio-ventricular Block to Prevent Cardiac Desynchronization.
Jean-Jacques BLANC (Brest, FR).
Comparison of Right Ventricular Septal Pacing and Right Ventricular Pacing in Patients Receiving a CRT-D.
Christophe LECLERCQ (Rennes, FR).
Optimal Method and Outcomes of Catheter Ablation of Persistent Atrial Fibrillation: Results of the Prospective, Randomized STAR AF 2 Trial.
Atul VERMA (Newmarket, CA).
EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): A Provider Perspective on Follow-up Costs and Net Financial Impact of Remote Monitoring in Six European Countries.
Hein HEIDBUCHEL (Hasselt, BE).
Hot Line: Myocardial infarction - 01/09/2014
Complete Versus Lesion Only Primary -PCI Trial (CVLPRIT): Treat the Infarct Related Artery Only or All Lesions.
Anthony H GERSHLICK (Leicester, GB).
In-ambulance versus in-cath Lab Administration of Ticagrelor in STEMI Patients Transferred for Primary PCI: The Randomized, Double-blind ATLANTIC Study.
Gilles MONTALESCOT (Paris, FR).
The British Heart Foundation Fractional Flow Reserve Versus Angiography in Guiding Management to Optimise Outcomes in Non-ST-segment Elevation Myocardial Infarction.
Colin BERRY (Glasgow, GB).
Nitric Oxide for Inhalation to Reduce Reperfusion Injury in Acute ST-elevation Myocardial Infarction.
Stefan JANSSENS (Leuven, BE).
Effect of Intravenous TRO40303 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-elevation Myocardial Infarction: Results of the MITOCARE Study.
Dan ATAR (Oslo, NO).
Hot Line: Coronary artery disease and atrial fibrillation - 02/09/2014
Perioperative Statin Treatment in Cardiac Surgery for the Prevention of Atrial Fibrillation and Perioperative Myocardial Damage: The Statin Therapy in Cardiac Surgery (STICS) Trial.
Barbara CASADEI (Oxford, GB).
The X-VERT Trial: A Comparison of Oral Rivaroxaban Once Daily With Dose-adjusted Vitamin K Antagonists in Patients With Nonvalvular Atrial Fibrillation Undergoing Elective Cardioversion.
Riccardo CAPPATO (San Donato Milanese, IT).
Recurrence of Arrhythmia Following Short-term Oral Amiodarone After Catheter Ablation for Atrial Fibrillation: A Double-blind, Randomized, Placebo-controlled Study.
Stine DARKNER (Copenhagen, DK).
Effect of High-intensity Statin Therapy on Atherosclerosis in Patients With ST-elevation Myocardial Infarction: Results of the Prospective, Longitudinal Intravascular Ultrasound Follow-up Study.
Lorenz RABER (Bern, CH).
IMPI Steroid Study: A Trial of Adjunctive Prednisolone in Tuberculous Pericarditis.
Bongani Mawethu MAYOSI (Cape Town, ZA).
